MedTrace Logo

Perioperative Neuroprotection of Stellate Ganglion Block

NCT02275247 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-05-20

No results posted yet for this study

Summary

To investigate whether stellate ganglion block is helpful to brain protection during cranial aneurysm surgery

Conditions

  • Intracranial Aneurysm

Interventions

DRUG

Stellate Ganglion Block

stellate ganglion block will be administered using either 6-8mL saline (Group 1) or 0.25% ropivacaine 6-8mL (Group 2)

Sponsors & Collaborators

  • General Hospital of Ningxia Medical University

    lead OTHER

Principal Investigators

  • Xu Wang · Gereral Hospital of Ningxia Medical University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-10-31
Completion
2016-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02275247 on ClinicalTrials.gov